AbbVie announces high sustained virologic response rates in Phase II studies

Press/Media: Press / Media

PeriodNov 19 2015

Media coverage

1

Media coverage

  • TitleAbbVie announces high sustained virologic response rates in Phase II studies
    Media name/outletHospital Pharmacy Europe
    CountryUnited Kingdom
    Date11/19/15
    PersonsFred Poordad